BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1390213)

  • 21. Three cases of platelet alloimmunisation associated with the presence of a novel platelet-specific antibody.
    Masters R; Taaning E
    Vox Sang; 1998; 75(3):242-6. PubMed ID: 9852414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and causes of refractoriness in multiply transfused patients.
    Legler TJ; Fischer I; Dittmann J; Simson G; Lynen R; Humpe A; Riggert J; Schleyer E; Kern W; Hiddemann W; Köhler M
    Ann Hematol; 1997 Apr; 74(4):185-9. PubMed ID: 9174547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of platelet alloantibodies by flow cytometry. Characterization and clinical significance.
    Rosenfeld CS; Bodensteiner DC
    Am J Clin Pathol; 1986 Feb; 85(2):207-12. PubMed ID: 3946304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
    Hebbar M; Kaplan C; Caulier MT; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P
    Br J Haematol; 1996 Jul; 94(1):112-5. PubMed ID: 8757517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
    Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
    Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet antibody screening in patients with leukemia and aplastic anemia.
    Chow MP; Yung CH; Tzeng JL; Hu HY; Lin WM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):237-41. PubMed ID: 1646672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
    Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
    Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
    Lo SC; Lin DT; Lin SW; Chang JS
    J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies.
    Hopkins M; Lucas G; Calvert A; Bendukidze N; Green F; Kotecha K; Poles A
    Transfusion; 2017 May; 57(5):1267-1271. PubMed ID: 28236317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of alloimmunization in platelet survival studies.
    Mueller-Eckhardt G; Breidenbach M; Mahn I; Mueller-Eckhardt C
    Blut; 1980 Aug; 41(2):93-9. PubMed ID: 7437528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.
    Vongchan P; Nawarawong W; Linhardt RJ
    Am J Clin Pathol; 2008 Sep; 130(3):455-66. PubMed ID: 18701420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet transfusion refractoriness and anti-HLA immunization.
    Blandin L; Dougé A; Fayard A; Bay JO; Berlie G; Pereira B; Lemal R; Rouzaire P
    Transfusion; 2021 Jun; 61(6):1700-1704. PubMed ID: 33709433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the microplate enzyme-linked assay with isolation of glycoprotein IIb/IIIa from platelet membranes: comparison with immunofluorescent tests and monoclonal antibodies].
    Maślanka K; Brojer E; Gromadzka G; Zupańska B
    Acta Haematol Pol; 1993; 24(4):373-9. PubMed ID: 8303984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elution of granulocyte and platelet antibodies.
    Helmerhorst FM; van Oss CJ; Bruynes EC; Engelfriet CP; von dem Borne AE
    Vox Sang; 1982; 43(4):196-204. PubMed ID: 6182693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA; Zulli R; Soares S; Castro Vd; Moraes-Souza H
    Clinics (Sao Paulo); 2011; 66(1):35-40. PubMed ID: 21437433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.